LA JOLLA, CA, FEBRUARY 10, 2004—A human pilot trial comparing a probiotic form of CoQ10 (CoQ10+ GPM™) and a chemically isolated form of CoQ10 (USP), found that CoQ10+ was significantly more bio-available, according to Dr. Taryn Forrelli, Technical Support Director, New Chapter Corporation. The results were revealed in an abstract presentation by Joseph A. Vinson, Ph.D., during the Scripps Clinic Natural Supplements Conference.
“There are many different commercial forms of CoQ10, a natural compound found in human tissue, organs and blood plasma,” explained Vinson. “In the blood, CoQ10 can protect against the oxidizing of the bad cholesterol, LDL, which if uncorrected can lead to atherosclerosis. CoQ10 can also improve the utilization of oxygen in the heart. In a blood plasma bioavailability comparison of CoQ10+GPM and the USP form, we found the CoQ10+ to be three times more bioavailable,” said Vinson.
The random, blinded cross-over study was conducted among 18 fasting adults, with blood samples being taken at 0, 2, 4, 6, 8 and 24-hour intervals.
“In addition, an in vitro LDL+VLDC oxidation assay showed that CoQ10+ was 20 times more powerful an antioxidant than the other form,” added Vinson.
New Chapter, Inc. of Brattleboro, VT manufacturers Probiotic CoQ10, which contains CoQ10+.
# # #